Universe Pharmaceuticals INC (NASDAQ:UPC) Sees Significant Drop in Short Interest

Universe Pharmaceuticals INC (NASDAQ:UPC) saw a large drop in short interest in September. As of September 30th, there was short interest totaling 43,865 shares, a drop of 42.2% from the September 15th total of 75,844 shares. Based on an average daily volume of 40,506 shares, the short-interest ratio is currently 1.1 days. Approximately 2.0% of the company’s stock are short sold.

Analyst Upgrades and Downgrades

Several equities research analysts recently issued reports on UPC shares. Weiss Ratings raised shares of Universe Pharmaceuticals from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Wednesday, July 29th. Wall Street Zen raised shares of Universe Pharmaceuticals to a “hold” rating in a research report on Saturday, August 29th. One equities research analyst has rated the stock with a Sell rating. According to MarketBeat, Universe Pharmaceuticals currently has an average rating of “Sell”.

Universe Pharmaceuticals Stock Performance

NASDAQ UPC traded down $0.14 during midday trading on Friday, hitting $4.01. The company had a trading volume of 4,387 shares, compared to its average volume of 703,799. The firm has a fifty day simple moving average of $4.77 and a two-hundred day simple moving average of $4.08. Universe Pharmaceuticals has a fifty-two week low of $2.00 and a fifty-two week high of $17.96. The company has a debt-to-equity ratio of 0.04, a quick ratio of 3.90 and a current ratio of 4.05.

Universe Pharmaceuticals (NASDAQ:UPC) last issued its earnings results on Wednesday, July 29th. The company reported ($1.38) EPS for the quarter. The company had revenue of $4.52 million during the quarter.

Universe Pharmaceuticals Company Profile

Universe Pharmaceuticals Inc (NASDAQ: UPC) is a China-based pharmaceutical company engaged in the development, manufacture and sale of traditional Chinese medicine (TCM) products and other healthcare offerings. The company serves consumers primarily through pharmaceutical distributors, retail pharmacies and other sales channels in China.

Universe Pharmaceuticals’ product portfolio includes over-the-counter and prescription pharmaceutical products, as well as healthcare and nutritional products.